The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.


Updates from The Motley Fool

Latest updates on AngioDynamics from Fool.com.
Why AngioDynamics Shares Tumbled

Although we don't believe in timing the market or panicking over market movements, we do like to ...

3 Predictions for Next Week

I went out on a limb last week , and now it's time to see how that decision played out. I predi...

AngioDynamics Goes Red

AngioDynamics ( Nasdaq: ANGO     ) reported earnings on April 4. Here are the numbers you need...



Stock Performance

View Interactive ANGO Charts
Sponsored by

Key Data Points

Primary metrics and data points about AngioDynamics.
Current Price: $17.04
Prev Close: $17.11
Open: $17.07
Bid: $15.51
Ask: $17.66
Day's Range: $16.86 - $17.15
52wk Range: $9.71 - $17.64
Volume: 319,049
Avg Vol 355,940
Market Cap: $618M
P/E (ttm): -14.88
EPS (ttm): ($1.15)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about AngioDynamics.
CAPS Rating 3 out of 5
 
114 Outperform
15 Underperform
CAPS All Stars
 
32 Outperform
5 Underperform

How do you think AngioDynamics will perform against the market?



You pick for AngioDynamics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph DeVivo, CEO

28% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AngioDynamics.

The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT